Homocysteine up-regulates vascular transmembrane chemokine CXCL16 and induces CXCR6+ lymphocyte recruitment in vitro and in vivo

Journal of Cellular and Molecular Medicine

Volumn 12, Issue 5A, 2008, Pages 1700-1709

  Postea, O ^a,b   Koenen, R R ^a   Hristov, M ^a   Weber, C ^a   Ludwig, A ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Atherosclerosis; Chemokines; Homocysteine; PPAR ; Scavenger

Indexed keywords

ANTIOXIDANT; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR; CXCR6 PROTEIN, HUMAN; CXCR6 PROTEIN, MOUSE; GRANULOCYTE CHEMOTACTIC PROTEIN 2; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; VIRUS RECEPTOR;

ANIMAL; ARTICLE; BLOOD VESSEL; CELL ADHESION; CELL CULTURE; CELL MEMBRANE; CELL MOTION; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; GENETICS; HUMAN; LYMPHOCYTE; METABOLISM; MOUSE; UPREGULATION;

ANIMALS; ANTIOXIDANTS; BLOOD VESSELS; CELL ADHESION; CELL MEMBRANE; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL6; ENDOTHELIAL CELLS; HOMOCYSTEINE; HUMANS; LIPOPROTEINS, LDL; LYMPHOCYTES; MICE; PPAR GAMMA; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR; RECEPTORS, VIRUS; UP-REGULATION;

MUS;

EID: 54149111582     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00223.x     Document Type: Article

References (40)

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005 352 : 1685 95.
2. Ross R, Masuda J, Raines EW. Cellular interactions, growth factors, and smooth muscle proliferation in atherogenesis. Ann N Y Acad Sci. 1990 598 : 102 12.
3. Liehn EA, Zernecke A, Postea O, Weber C. Chemokines: Inflammatory mediators of atherosclerosis. Arch Physiol Biochem. 2006 112 : 229 38.
4. Weber C, Schober A, Zernecke A. Chemokines: key regulators of mononu-clear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol. 2004 24 : 1997 2008.
5. Matloubian M, David A, Engel S, Ryan JE, Cyster JG. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol. 2000 1 : 298 304.
6. Wilbanks A, Zondlo SC, Murphy K, Mak S, Soler D, Langdon P, Andrew DP, Wu L, Briskin M. Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines. J Immunol. 2001 166 : 5145 54.
7. Minami M, Kume N, Shimaoka T, Kataoka H, Hayashida K, Akiyama Y, Nagata I, Ando K, Nobuyoshi M, Hanyuu M, Komeda M, Yonehara S, Kita T. Expression of SR-PSOX, a novel cell-surface scavenger receptor for phos-phatidylserine and oxidized LDL in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2001 21 : 1796 800.
8. Wuttge DM, Zhou X, Sheikine Y, Wagsater D, Stemme V, Hedin U, Stemme S, Hansson GK, Sirsjo A. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2004 24 : 750 5.
9. Shimaoka T, Kume N, Minami M, Hayashida K, Kataoka H, Kita T, Yonehara S. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem. 2000 275 : 40663 6.
10. Shimaoka T, Nakayama T, Fukumoto N, Kume N, Takahashi S, Yamaguchi J, Minami M, Hayashida K, Kita T, Ohsumi J, Yoshie O, Yonehara S. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J Leukoc Biol. 2004 75 : 267 74.
11. Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, Hartmann D, Sedlacek R, Dietrich S, Muetze B, Schuster B, Kallen KJ, Saftig P, Rose-John S, Ludwig A. The trans-membrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol. 2004 172 : 6362 72.
12. Harker LA, Ross R, Slichter SJ, Scott CR. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 1976 58 : 731 41.
13. Weiss N, Heydrick SJ, Postea O, Keller C, Keaney JF, Jr., Loscalzo J. Influence of hyperhomocysteinemia on the cellular redox state-impact on homocysteine-induced endothelial dysfunction. Clin Chem Lab Med. 2003 41 : 1455 61.
14. Poddar R, Sivasubramanian N, DiBello PM, Robinson K, Jacobsen DW. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation. 2001 103 : 2717 23.
15. Koga T, Claycombe K, Meydani M. Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. Atherosclerosis. 2002 161 : 365 74.
16. Wang G, Woo CW, Sung FL, Siow YL, O K. Increased monocyte adhesion to aortic endothelium in rats with hyperhomocys-teinemia: role of chemokine and adhesion molecules. Arterioscler Thromb Vasc Biol. 2002 22 : 1777 83.
17. Zhang Q, Zeng X, Guo J, Wang X. Oxidant stress mechanism of homocysteine potentiating Con A-induced proliferation in murine splenic T lymphocytes. Cardiovasc Res. 2002 53 : 1035 42.
18. Postea O, Krotz F, Henger A, Keller C, Weiss N. Stereospecific and redox-sensi-tive increase in monocyte adhesion to endothelial cells by homocysteine. Arterioscler Thromb Vasc Biol. 2006 26 : 508 13.
19. Murao K, Imachi H, Momoi A, Sayo Y, Hosokawa H, Sato M, Ishida T, Takahara J. Thiazolidinedione inhibits the production of monocyte chemoattractant protein-1 in cytokine-treated human vascular endothelial cells. FEBS Lett. 1999 454 : 27 30.
20. Rocic P, Rezk B, Lucchesi PA. PPAR-gamma agonists decrease hyperhomcys-teinemia and cardiac dysfunction: new hope for ailing diabetic hearts? Am J Physiol Heart Circ Physiol. 2006 291 : H26 8.
21. Marx N, Bourcier T, Sukhova GK, Libby P, Plutzky J. PPARgamma activation in human endothelial cells increases plas-minogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol. 1999 19 : 546 51.
22. Hunt MJ, Tyagi SC. Peroxisome prolifera-tors compete and ameliorate Hcy-mediated endocardial endothelial cell activation. Am J Physiol Cell Physiol. 2002 283 : C1073 9.
23. Jakubowski H. Biosynthesis and reactions of homocysteine thiolactone. In : Carmel R, Jacobson DW, eds. Homocysteine in health and disease. Cambrigde : Cambridge University Press 2001.
24. Scholz F, Schulte A, Adamski F, Hundhausen C, Mittag J, Schwarz A, Kruse ML, Proksch E, Ludwig A. Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin. J Invest Dermatol. 2007 127 : 1444 55.
25. Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA. 1983 80 : 3734 7.
26. Mutin M, Dignat-George F, Sampol J. Immunologic phenotype of cultured endothelial cells: quantitative analysis of cell surface molecules. Tissue Antigens. 1997 50 : 449 58.
27. Dwivedi A, Anggard EE, Carrier MJ. Oxidized LDL-mediated monocyte adhesion to endothelial cells does not involve NFkappaB. Biochem Biophys Res Commun. 2001 284 : 239 44.
28. Ryan QC, Goonewardene IM, Murasko DM. Maintenance of normal T lymphocyte function after transfection with SV40 large T. Cell Immunol. 1993 149 : 65 81.
29. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999 340 : 115 26.
30. Zhang HS, Cao EH, Qin JF. Intracellular redox status modulates monocyte chemoattractant protein-1 expression stimulated by homocysteine in endothelial cells. J Cardiovasc Pharmacol. 2003 42 : 258 65.
31. Zeng X, Dai J, Remick DG, Wang X. Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes. Circ Res. 2003 93 : 311 20.
32. Galkina E, Harry BL, Ludwig A, Liehn EA, Sanders JM, Bruce A, Weber C, and Ley K. CXCR6 promotes atherosclerosis by supporting T cell homing, interferon gamma production and macrophage accumulation in the aortic wall. Circulation. 2007 116 : 1801 11.
33. Chen XP, Zhang TT, Du GH. Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis? Cardiovasc Drug Rev. 2007 25 : 146 61.
34. Nagase M, Ando K, Nagase T, Kaname S, Sawamura T, Fujita T. Redox-sensitive regulation of lox-1 gene expression in vascular endothelium. Biochem Biophys Res Commun. 2001 281 : 720 5.
35. Aslanian AM, Charo IF. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation. 2006 114 : 583 90.
36. Delerive P, Martin-Nizard F, Chinetti G, Trottein F, Fruchart JC, Najib J, Duriez P, Staels B. Peroxisome proliferator-acti-vated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ Res. 1999 85 : 394 402.
37. Jackson SM, Parhami F, Xi XP, Berliner JA, Hsueh WA, Law RE, Demer LL. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol. 1999 19 : 2094 104.
38. Brude IR, Finstad HS, Seljeflot I, Drevon CA, Solvoll K, Sandstad B, Hjermann I, Arnesen H, Nenseter MS. Plasma homocys-teine concentration related to diet, endothe-lial function and mononuclear cell gene expression among male hyperlipidaemic smokers. Eur J Clin Invest. 1999 29 : 100 8.
39. Au-Yeung KK, Woo CW, Sung FL, Yip JC, Siow YL, O K. Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress. Circ Res. 2004 94 : 28 36.
40. Lehrke M, Millington SC, Lefterova M, Cumaranatunge RG, Szapary P, Wilensky R, Rader DJ, Lazar MA, Reilly M P. CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans. J Am Coll Cardiol. 2007 49 : 442 9.